These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27346379)

  • 21. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
    Bauer K; Richter M; Wutzler P; Schmidtke M
    Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
    Mohr PG; Geyer H; McKimm-Breschkin JL
    Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and prophylaxis of influenza and the problem of resistance to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1087-95. PubMed ID: 26400894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of influenza B viruses with reduced sensitivity to neuraminidase inhibitor in Morocco during 2014/15 season.
    Elfalki F; Ihazmad H; Bimouhen A; Regragui Z; Benkaroum S; Bakri Y; Barakat A
    East Mediterr Health J; 2016 Oct; 22(7):453-459. PubMed ID: 27714739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
    Mungall BA; Xu X; Klimov A
    Virus Res; 2004 Jul; 103(1-2):195-7. PubMed ID: 15163509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
    Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
    PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2016 Sep; 22(9):605-10. PubMed ID: 27493024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.
    Okomo-Adhiambo M; Mishin VP; Sleeman K; Saguar E; Guevara H; Reisdorf E; Griesser RH; Spackman KJ; Mendenhall M; Carlos MP; Healey B; St George K; Laplante J; Aden T; Chester S; Xu X; Gubareva LV
    Antiviral Res; 2016 Apr; 128():28-35. PubMed ID: 26808479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
    [No Abstract]   [Full Text] [Related]  

  • 33. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostics of viral respiratory infections in hospitalized patients and ambulatory patients from SENTINEL program during 2004/05 season in Poland].
    Brydak LB; Lietzau G; Machała M
    Pol Arch Med Wewn; 2005 Oct; 114(4):958-67. PubMed ID: 16789521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors.
    Perez-Sautu U; Pozo F; Cuesta I; Monzon S; Calderon A; Gonzalez M; Molinero M; Lopez-Miragaya I; Rey S; Cañizares A; Rodriguez G; Gonzalez-Velasco C; Lackenby A; Casas I
    Euro Surveill; 2014 Jul; 19(27):14-20. PubMed ID: 25033052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.
    van der Vries E; Ip DK; Cowling BJ; Zhang JD; Tong X; Wojtowicz K; Schutten M; Boucher CA
    J Infect Dis; 2016 Jan; 213(2):183-90. PubMed ID: 26160744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
    Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
    J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
    Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
    Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].
    Huang W; Li X; Tan M; Wei H; Cheng Y; Guo J; Wang Z; Xiao N; Wang D; Shu Y
    Bing Du Xue Bao; 2015 Mar; 31(2):152-6. PubMed ID: 26164940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Susceptibility of human influenza A (H3N2) viruses to neuraminidase inhibitors isolated during 2011-2012 in China].
    Huang W; Tan M; Zhao X; Cheng Y; Li X; Guo J; Wei H; Xiao N; Wang Z; Wang D; Shu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):481-4. PubMed ID: 26310330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.